Vanguard Personalized Indexing Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$709K	Buy	12,550 +2,345	+23%	+$137K	0.01%	1101
2025 Q4	$606K	Sell	10,205 -2,877	-22%	-$157K	0.01%	1155
2025 Q3	$709K	Sell	13,082 -911	-7%	-$52.1K	0.01%	1073
2025 Q2	$769K	Sell	13,993 -10,433	-43%	-$614K	0.01%	1004
2025 Q1	$1.73M	Buy	24,426 +2,550	+12%	+$172K	0.03%	547
2024 Q4	$1.44M	Buy	21,876 +4,888	+29%	+$327K	0.02%	604
2024 Q3	$1.19M	Buy	16,988 +6,357	+60%	+$531K	0.02%	685
2024 Q2	$875K	Buy	10,631 +1,356	+15%	+$113K	0.02%	741
2024 Q1	$810K	Sell	9,275 -26	-0.3%	-$2.33K	0.02%	767
2023 Q4	$897K	Sell	9,301 -1,565	-14%	-$138K	0.02%	716
2023 Q3	$961K	Sell	10,866 -850	-7%	-$75.6K	0.03%	576
2023 Q2	$1.02M	Buy	11,716 +436	+4%	+$41K	0.03%	559
2023 Q1	$1.1M	Sell	11,280 -184	-2%	-$19.1K	0.04%	485
2022 Q4	$1.19M	Sell	11,464 -126	-1%	-$11.8K	0.05%	442
2022 Q3	$982K	Buy	11,590 +2,472	+27%	+$220K	0.04%	486
2022 Q2	$756K	Buy	9,118 +5,111	+128%	+$407K	0.04%	603
2022 Q1	$309K	Sell	4,007 -4	-0.1%	-$335	0.02%	990
2021 Q4	$354K	Buy	+4,011	New	+$331K	0.02%	819
2021 Q3	–	Sell	-4,294	Closed	-$358K	–	986
2021 Q2	$358K	Buy	+4,294	New	+$340K	0.04%	656